You are not getting it right. The Phase 1a/b trial is fully funded and it will provide proof-of-concept clinical data on cardioprotection, m6A (FTO) and anticancer activity. The phase 2 provides the gold standard, placebo-controlled, double blind clinical data required for accelerated approval.
RAC Price at posting:
87.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)